Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niels Hansen

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
Scientific Reports|November 12, 2024
Author Correction: Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Neurology|October 11, 2023
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive DeclineMelina Stark, Steffen Wolfsgruber, Luca Kleineidam, et al.
Brain Communications|February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrumLena Haag, Elisa Lancini, Renat Yakupov, et al.
Research Square|September 18, 2023
Whole-body modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Molecular Psychiatry|April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseDavid Mengel, Ester Soter, Julia Maren Ott, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-ADHannah Baumeister, Falk Lüsebrink, Luca Kleineidam, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 26, 2024
Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyLara Blömeke, Fabian Rehn, Victoria Kraemer-Schulien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 28, 2024
Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's diseaseJonathan Vogelgsang, Niels Hansen, Melina Stark, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 18, 2023
Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohortsXueyan Jiang, Xiaochen Hu, Marcel Daamen, et al.
Brain, Behavior, and Immunity|February 3, 2024
KCNA2 IgG autoimmunity in neuropsychiatric diseasesFriederike A Arlt, Ramona Miske, Marie-Luise Machule, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Scientific Reports|November 12, 2024
Author Correction: Whole-body metabolic modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Neurology|October 11, 2023
Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive DeclineMelina Stark, Steffen Wolfsgruber, Luca Kleineidam, et al.
Brain Communications|February 10, 2025
CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer's disease spectrumLena Haag, Elisa Lancini, Renat Yakupov, et al.
Research Square|September 18, 2023
Whole-body modelling reveals microbiome and genomic interactions on reduced urine formate levels in Alzheimer's diseaseFilippo Martinelli, Almut Heinken, Ann-Kristin Henning, et al.
Molecular Psychiatry|April 17, 2025
Blood biomarkers confirm subjective cognitive decline (SCD) as a distinct molecular and clinical stage within the NIA-AA framework of Alzheimer´s diseaseDavid Mengel, Ester Soter, Julia Maren Ott, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Subtyping and staging of Alzheimer's disease from routine structural MRI with PHASE-ADHannah Baumeister, Falk Lüsebrink, Luca Kleineidam, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 26, 2024
Aβ oligomers peak in early stages of Alzheimer's disease preceding tau pathologyLara Blömeke, Fabian Rehn, Victoria Kraemer-Schulien, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 28, 2024
Plasma amyloid beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer's diseaseJonathan Vogelgsang, Niels Hansen, Melina Stark, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 18, 2023
Altered limbic functional connectivity in individuals with subjective cognitive decline: Converging and diverging findings across Chinese and German cohortsXueyan Jiang, Xiaochen Hu, Marcel Daamen, et al.
Brain, Behavior, and Immunity|February 3, 2024
KCNA2 IgG autoimmunity in neuropsychiatric diseasesFriederike A Arlt, Ramona Miske, Marie-Luise Machule, et al.
Pageof 21